Peripheral arterial disease is a severe pathology. Several methods have been tested in order to increase the patency rate and the quality of life. The superficial femoral artery is considered a very difficult region due to the continuous movement of the leg that modify the length and the morphology of this vessel. Since their introduction, drug-coated balloons have been correlated with an increased patency rate. Several studies have been performed and nowadays a level 1 evidence is available. Not all the lesions can be treated successfuly with drug-coated balloons. For example in case of heavely calcified lesions vessel preparation is required. This can be performed with atherectomy, scorig balloon, lithoplasty in order to debulk the lesion...
Objective This retrospective single-center study aimed to analyze immediate and follow-up results of...
Objectives This study sought to compare paclitaxel-eluting balloon (PEB) with conventional percutane...
ObjectiveAlthough drug-eluting balloons (DEBs) have shown promising results treating de novo (DN) at...
Mohamed Barkat,1 Francesco Torella,1 George A Antoniou2 1Liverpool Vascular and Endovascular Service...
Monika Herten,1 Giovanni B Torsello,1,2 Eva Schönefeld,3 Stefan Stahlhoff2 1Department of Vascu...
Sho Torii, Frank D Kolodgie, Renu Virmani, Aloke V Finn Cardiovascular Pathology, CVPath Institute, ...
Background Atherosclerotic peripheral artery disease (PAD) is common and results in limitations in q...
BackgroundTreatment of femoropopliteal artery disease by percutaneous transluminal angioplasty (PTA)...
Drug-coated balloons (DCBs) have become an established therapy for the treatment of above-the-knee p...
AbstractBackgroundEvidence from large, randomized, controlled peripheral artery disease trials repor...
Objectives: In this study, we aimed to evaluate the one-year follow-up findings of endovascular trea...
Treatment of femoropopliteal artery disease by percutaneous transluminal angioplasty (PTA) is limite...
Abstract Background Drug-coated balloons (DCBs) have shown superiority in the endovascular treatment...
Abstract Background Drug-coated balloons (DCBs) have significantly changed endovascular therapy (EVT...
Background: The femoropopliteal artery is most frequently involved artery in peripheral artery disea...
Objective This retrospective single-center study aimed to analyze immediate and follow-up results of...
Objectives This study sought to compare paclitaxel-eluting balloon (PEB) with conventional percutane...
ObjectiveAlthough drug-eluting balloons (DEBs) have shown promising results treating de novo (DN) at...
Mohamed Barkat,1 Francesco Torella,1 George A Antoniou2 1Liverpool Vascular and Endovascular Service...
Monika Herten,1 Giovanni B Torsello,1,2 Eva Schönefeld,3 Stefan Stahlhoff2 1Department of Vascu...
Sho Torii, Frank D Kolodgie, Renu Virmani, Aloke V Finn Cardiovascular Pathology, CVPath Institute, ...
Background Atherosclerotic peripheral artery disease (PAD) is common and results in limitations in q...
BackgroundTreatment of femoropopliteal artery disease by percutaneous transluminal angioplasty (PTA)...
Drug-coated balloons (DCBs) have become an established therapy for the treatment of above-the-knee p...
AbstractBackgroundEvidence from large, randomized, controlled peripheral artery disease trials repor...
Objectives: In this study, we aimed to evaluate the one-year follow-up findings of endovascular trea...
Treatment of femoropopliteal artery disease by percutaneous transluminal angioplasty (PTA) is limite...
Abstract Background Drug-coated balloons (DCBs) have shown superiority in the endovascular treatment...
Abstract Background Drug-coated balloons (DCBs) have significantly changed endovascular therapy (EVT...
Background: The femoropopliteal artery is most frequently involved artery in peripheral artery disea...
Objective This retrospective single-center study aimed to analyze immediate and follow-up results of...
Objectives This study sought to compare paclitaxel-eluting balloon (PEB) with conventional percutane...
ObjectiveAlthough drug-eluting balloons (DEBs) have shown promising results treating de novo (DN) at...